Company intelligence / Profile preview

Bolder BioPATH

Boulder, Colorado, United Statesinotiv.com ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

Bolder BioPATH is a contract pharmacology and pathology organization specializing in in vivo models of autoimmune and inflammatory diseases. It provides efficacy and toxicity data to support advancement of client drug candidates—proteins or small molecules—to IND/NDA stage. The company does not have its own clinical pipeline but supports clients' programs with high-quality preclinical data.

Therapeutic areas: ImmunologyHematologyDermatologyRheumatologyGastroenterology
Modalities: Small moleculeProtein
Industry: Contract Research Organization

Beyond the preview

Go deeper on Bolder BioPATH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bolder BioPATH.

Explore the full profile